Comparison of the efficacy and safety of perioperative immunochemotherapeutic strategies for locally advanced esophageal cancer: a systematic review and network meta-analysis

Jiao Zhang, Peixi Zhao, Rui Xu, Le Han, Wenjuan Chen, Yili Zhang · 2024

Read Comparison of the efficacy and safety of perioperative immunochemotherapeutic strategies for locally advanced esophageal cancer: a systematic review and network meta-analysis by Jiao Zhang, Peixi Zhao, Rui Xu, Le Han, Wenjuan Chen, Yili Zhang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11659204.txt.

Description

Jiao Zhang and five co-authors wrote this 2024 network meta-analysis ranking drug strategies given around surgery for advanced esophageal cancer. Adding immune checkpoint drugs to chemotherapy before surgery has multiplied the options faster than trials can compare them head to head. The team pooled fourteen studies, all from China, covering 1,139 patients, and compared regimens indirectly across many outcomes.

Immune-plus-chemo strategies beat traditional pre-surgery therapy on tumor shrinkage and complete disappearance under the microscope. Camrelizumab with chemotherapy led on the deepest responses; pembrolizumab with chemotherapy led on overall response measures. Clean surgical removal rates and side-effect burdens did not differ significantly between strategies. The commonest problems were blood toxicity and gut damage, mostly manageable. The authors offer the rankings as decision support, with the caveat that the evidence base is one country's.

Catalog record

CREATORJiao Zhang, Peixi Zhao, Rui Xu, Le Han, Wenjuan Chen, Yili Zhang
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11659204

Browse the full library · About the Tower of Babel